tiprankstipranks
Advertisement
Advertisement
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
PremiumThe FlyQuantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
11d ago
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
Premium
Company Announcements
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
14d ago
Quantum BioPharma Taps MS Expert to Lead Phase 2 Trial of Lucid-MS
Premium
Company Announcements
Quantum BioPharma Taps MS Expert to Lead Phase 2 Trial of Lucid-MS
15d ago
Quantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results
PremiumCompany AnnouncementsQuantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results
1M ago
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS
Premium
Company Announcements
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS
4M ago
Quantum Group completes dosing in 180-day study of Lucid-MS
Premium
The Fly
Quantum Group completes dosing in 180-day study of Lucid-MS
4M ago
Quantum BioPharma Closes Private Placement, Enhances Governance
PremiumCompany AnnouncementsQuantum BioPharma Closes Private Placement, Enhances Governance
4M ago
Quantum BioPharma Ends Market Offering Agreement
Premium
Company Announcements
Quantum BioPharma Ends Market Offering Agreement
4M ago
Quantum BioPharma’s Lawsuit Highlighted in CTV’s W5 Series
Premium
Company Announcements
Quantum BioPharma’s Lawsuit Highlighted in CTV’s W5 Series
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100